David K Hooper

Summary

Affiliation: Cincinnati Children's Hospital Medical Center
Country: USA

Publications

  1. doi request reprint Reliable individualized monitoring improves cholesterol control in kidney transplant recipients
    David K Hooper
    Division of Nephrology and Hypertension, Cincinnati Children s Hospital Medical Center, MLC 7022, 3333 Burnet Ave, Cincinnati, OH 45229, USA
    Pediatrics 131:e1271-9. 2013
  2. doi request reprint Interaction between tacrolimus and intravenous nicardipine in the treatment of post-kidney transplant hypertension at pediatric hospitals
    David K Hooper
    Division of Nephrology and Hypertension, Cincinnati Children s Hospital Medical Center, James M Anderson Center for Health Systems Excellence, Cincinnati, OH 45229, USA
    Pediatr Transplant 15:88-95. 2011
  3. doi request reprint Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantation
    David K Hooper
    Division of Nephrology and Hypertension, Cincinnati Children s Hospital Medical Center, Cincinnati, OH, USA
    Transplantation 93:806-12. 2012
  4. pmc The influence of context on quality improvement success in health care: a systematic review of the literature
    Heather C Kaplan
    Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    Milbank Q 88:500-59. 2010
  5. pmc The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study
    David K Hooper
    Division of Nephrology and Hypertension, Cincinnati Children s Hospital Medical Center, Cincinnati, OH, USA
    Pediatr Nephrol 28:939-49. 2013

Collaborators

Detail Information

Publications5

  1. doi request reprint Reliable individualized monitoring improves cholesterol control in kidney transplant recipients
    David K Hooper
    Division of Nephrology and Hypertension, Cincinnati Children s Hospital Medical Center, MLC 7022, 3333 Burnet Ave, Cincinnati, OH 45229, USA
    Pediatrics 131:e1271-9. 2013
    ..To develop and evaluate a system for reliable and efficient individualized risk-based monitoring of cholesterol and 11 other tests after kidney transplantation in children...
  2. doi request reprint Interaction between tacrolimus and intravenous nicardipine in the treatment of post-kidney transplant hypertension at pediatric hospitals
    David K Hooper
    Division of Nephrology and Hypertension, Cincinnati Children s Hospital Medical Center, James M Anderson Center for Health Systems Excellence, Cincinnati, OH 45229, USA
    Pediatr Transplant 15:88-95. 2011
    ..In multivariate analysis, only CIVN significantly predicted AEI (AOR 2.8, 95% CI 1.29-6.04). Thus, until clinical studies to fully characterize this interaction are completed, CIVN should be used with caution in TAC-treated individuals...
  3. doi request reprint Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantation
    David K Hooper
    Division of Nephrology and Hypertension, Cincinnati Children s Hospital Medical Center, Cincinnati, OH, USA
    Transplantation 93:806-12. 2012
    ....
  4. pmc The influence of context on quality improvement success in health care: a systematic review of the literature
    Heather C Kaplan
    Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    Milbank Q 88:500-59. 2010
    ..The mixed results of success among QI initiatives may be due to differences in the context of these initiatives...
  5. pmc The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study
    David K Hooper
    Division of Nephrology and Hypertension, Cincinnati Children s Hospital Medical Center, Cincinnati, OH, USA
    Pediatr Nephrol 28:939-49. 2013
    ..Cardiovascular disease is the leading cause of increased mortality for adolescents with advanced kidney disease. The quality of preventive cardiovascular care may impact long-term outcomes for these patients...